Wanamarta A H, van Rijn J, Blank L E, Haveman J, van Zandwijk N, Joenje H
Institute of Human Genetics, Free University, Amsterdam, The Netherlands.
J Cancer Res Clin Oncol. 1989;115(4):340-4. doi: 10.1007/BF00400960.
N-Acetylcysteine is currently being considered as a possible selective protector against pulmonary toxicity resulting from X-rays or chemotherapeutic treatment, but its clinical application awaits evidence that it does not interfere with the efficient killing of tumor cells. The capacity of N-acetylcysteine to protect against the antitumor activity of X-rays and of bleomycin was evaluated in a clonogenic cell-survival assay using SW-1573 human squamous lung carcinoma cells as a tumor model. Using the highest non-toxic dose of N-acetylcysteine (incubation for 2 days in the continuous presence of 10 mM) no effect on clonogenic cell killing by X-rays or bleomycin treatment could be detected, even though a twofold enhancement of endogenous glutathione was effectuated. Our data thus indicate that clinically relevant concentrations of N-acetylcysteine are incapable of protecting tumor cells against clonogenic killing by X-rays and by bleomycin.
N-乙酰半胱氨酸目前被视为一种可能针对X射线或化疗所致肺毒性的选择性保护剂,但其临床应用尚需证据表明它不会干扰肿瘤细胞的有效杀伤。在一项克隆形成细胞存活试验中,以SW-1573人肺鳞状癌细胞作为肿瘤模型,评估了N-乙酰半胱氨酸对抗X射线和博来霉素抗肿瘤活性的能力。使用最高无毒剂量的N-乙酰半胱氨酸(在10 mM持续存在的情况下孵育2天),未检测到对X射线或博来霉素处理的克隆形成细胞杀伤有任何影响,尽管内源性谷胱甘肽增加了两倍。因此,我们的数据表明,临床相关浓度的N-乙酰半胱氨酸无法保护肿瘤细胞免受X射线和博来霉素的克隆形成杀伤。